semaglutide and heart health cardiovascular outcomes align more closely with attained dose than achieved weight loss Wegovy, weight loss and cardiovascular

1 Diabetic retinopathy complications requiring treatment may be more common with semaglutide than with placebo

While nausea and fatigue dominate clinical discussions, some individuals report skin-related sensations including itching during their treatment journey

Knowing what to look for can prevent you from injecting medication that has lost its effectiveness or, worse, that could cause adverse reactions

It works by stimulating two receptors in the body, known as the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors

A 2024 study by Hathaway et al., which investigated more than 16,000 patients over a period of six years, raised ocular safety issues related to semaglutide

The difference between those two endpoints, 213 versus 178, could be the difference between still meeting clinical criteria for obesity and reaching a normal BMI range